BACKGROUND: Enchondromatosis is characterized by the presence of multiple benign cartilage lesions in bone. While Ollier disease is typified by multiple enchondromas, in Maffucci syndrome these are associated with hemangiomas. Studies evaluating the predictive value of clinical symptoms for development of secondary chondrosarcoma and prognosis are lacking. This multi-institute study evaluates the clinical characteristics of patients, to get better insight on behavior and prognosis of these diseases. METHOD: A retrospective study was conducted using clinical data of 144 Ollier and 17 Maffucci patients from 13 European centers and one national databank supplied by members of the European Musculoskeletal Oncology Society. RESULTS: Patients had multiple enchondromas in the hands and feet only (group I, 18%), in long bones including scapula and pelvis only (group II, 39%), and in both small and long/flat bones (group III, 43%), respectively. The overall incidence of chondrosarcoma thus far is 40%. In group I, only 4 patients (15%) developed chondrosarcoma, in contrast to 27 patients (43%) in group II and 26 patients (46%) in group III, respectively. The risk of developing chondrosarcoma is increased when enchondromas are located in the pelvis (odds ratio, 3.8; p = 0.00l). CONCLUSIONS: Overall incidence of development of chondrosarcoma is 40%, but may, due to age-dependency, increase when considered as a lifelong risk. Patients with enchondromas located in long bones or axial skeleton, especially the pelvis, have a seriously increased risk of developing chondrosarcoma, and are identified as the population that needs regular screening on early detection of malignant transformation.
BACKGROUND:Enchondromatosis is characterized by the presence of multiple benign cartilage lesions in bone. While Ollier disease is typified by multiple enchondromas, in Maffucci syndrome these are associated with hemangiomas. Studies evaluating the predictive value of clinical symptoms for development of secondary chondrosarcoma and prognosis are lacking. This multi-institute study evaluates the clinical characteristics of patients, to get better insight on behavior and prognosis of these diseases. METHOD: A retrospective study was conducted using clinical data of 144 Ollier and 17 Maffucci patients from 13 European centers and one national databank supplied by members of the European Musculoskeletal Oncology Society. RESULTS:Patients had multiple enchondromas in the hands and feet only (group I, 18%), in long bones including scapula and pelvis only (group II, 39%), and in both small and long/flat bones (group III, 43%), respectively. The overall incidence of chondrosarcoma thus far is 40%. In group I, only 4 patients (15%) developed chondrosarcoma, in contrast to 27 patients (43%) in group II and 26 patients (46%) in group III, respectively. The risk of developing chondrosarcoma is increased when enchondromas are located in the pelvis (odds ratio, 3.8; p = 0.00l). CONCLUSIONS: Overall incidence of development of chondrosarcoma is 40%, but may, due to age-dependency, increase when considered as a lifelong risk. Patients with enchondromas located in long bones or axial skeleton, especially the pelvis, have a seriously increased risk of developing chondrosarcoma, and are identified as the population that needs regular screening on early detection of malignant transformation.
Authors: M J Geirnaerdt; J Hermans; J L Bloem; H M Kroon; T L Pope; A H Taminiau; P C Hogendoorn Journal: AJR Am J Roentgenol Date: 1997-10 Impact factor: 3.959
Authors: Leida B Rozeman; Luca Sangiorgi; Inge H Briaire-de Bruijn; Pierre Mainil-Varlet; F Bertoni; Anne Marie Cleton-Jansen; Pancras C W Hogendoorn; Judith V M G Bovée Journal: Hum Mutat Date: 2004-12 Impact factor: 4.878
Authors: Makoto Hirata; Masato Sasaki; Rob A Cairns; Satoshi Inoue; Vijitha Puviindran; Wanda Y Li; Bryan E Snow; Lisa D Jones; Qingxia Wei; Shingo Sato; Yuning J Tang; Puviindran Nadesan; Jason Rockel; Heather Whetstone; Raymond Poon; Angela Weng; Stefan Gross; Kimberly Straley; Camelia Gliser; Yingxia Xu; Jay Wunder; Tak W Mak; Benjamin A Alman Journal: Proc Natl Acad Sci U S A Date: 2015-02-17 Impact factor: 11.205
Authors: William D Tap; Victor M Villalobos; Gregory M Cote; Howard Burris; Filip Janku; Olivier Mir; Murali Beeram; Andrew J Wagner; Liewen Jiang; Bin Wu; Sung Choe; Katharine Yen; Camelia Gliser; Bin Fan; Sam Agresta; Shuchi S Pandya; Jonathan C Trent Journal: J Clin Oncol Date: 2020-03-24 Impact factor: 44.544